Patient‐reported outcomes following neoadjuvant endocrine therapy, external beam radiation, and adjuvant continuous/intermittent endocrine therapy for locally advanced prostate cancer: A randomized phase III trial
Abstract Background We evaluated patient‐reported outcomes (PRO) during neoadjuvant androgen deprivation therapy (ADT) plus external beam radiation therapy (EBRT) followed by either adjuvant continuous ADT (CADT) or intermittent ADT (IADT) for patients with locally advanced prostate cancer (Pca). Me...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-05-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.3895 |
id |
doaj-4fc6d5a819fc4ff3b13b667c17fde309 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Akira Yokomizo Hirofumi Koga Kazuto Ito Yutaka Takezawa Motokiyo Komiyama Kazuo Nishimura Junji Yonese Katsuyoshi Hashine Naoya Masumori Gaku Arai Shiro Saito Mitsuru Shinohara Nobuaki Shimizu Atsushi Yamauchi Takefumi Satoh Tatsuo Tochigi Mikio Kobayashi Hiroyuki Fujimoto Ken‐ichi Kakimoto Iwao Fukui Taiji Tsukamoto Miwako Nozaki Katsuyuki Karasawa Masaru Hasumi Mikinobu Ohtani Hiromichi Ishiyama Masaaki Kuwahara Masaoki Harada Yasuo Ohashi Toshihiko Kotake Tadao Kakizoe Kazuhiro Suzuki Seiji Naito Hidetoshi Yamanaka National Research Project on Endocrine‐Radiation Combination Therapy for Locally Advanced Prostate Cancer investigators |
spellingShingle |
Akira Yokomizo Hirofumi Koga Kazuto Ito Yutaka Takezawa Motokiyo Komiyama Kazuo Nishimura Junji Yonese Katsuyoshi Hashine Naoya Masumori Gaku Arai Shiro Saito Mitsuru Shinohara Nobuaki Shimizu Atsushi Yamauchi Takefumi Satoh Tatsuo Tochigi Mikio Kobayashi Hiroyuki Fujimoto Ken‐ichi Kakimoto Iwao Fukui Taiji Tsukamoto Miwako Nozaki Katsuyuki Karasawa Masaru Hasumi Mikinobu Ohtani Hiromichi Ishiyama Masaaki Kuwahara Masaoki Harada Yasuo Ohashi Toshihiko Kotake Tadao Kakizoe Kazuhiro Suzuki Seiji Naito Hidetoshi Yamanaka National Research Project on Endocrine‐Radiation Combination Therapy for Locally Advanced Prostate Cancer investigators Patient‐reported outcomes following neoadjuvant endocrine therapy, external beam radiation, and adjuvant continuous/intermittent endocrine therapy for locally advanced prostate cancer: A randomized phase III trial Cancer Medicine external beam radiation therapy intermittent androgen deprivation therapy prostate cancer QOL neoadjuvant |
author_facet |
Akira Yokomizo Hirofumi Koga Kazuto Ito Yutaka Takezawa Motokiyo Komiyama Kazuo Nishimura Junji Yonese Katsuyoshi Hashine Naoya Masumori Gaku Arai Shiro Saito Mitsuru Shinohara Nobuaki Shimizu Atsushi Yamauchi Takefumi Satoh Tatsuo Tochigi Mikio Kobayashi Hiroyuki Fujimoto Ken‐ichi Kakimoto Iwao Fukui Taiji Tsukamoto Miwako Nozaki Katsuyuki Karasawa Masaru Hasumi Mikinobu Ohtani Hiromichi Ishiyama Masaaki Kuwahara Masaoki Harada Yasuo Ohashi Toshihiko Kotake Tadao Kakizoe Kazuhiro Suzuki Seiji Naito Hidetoshi Yamanaka National Research Project on Endocrine‐Radiation Combination Therapy for Locally Advanced Prostate Cancer investigators |
author_sort |
Akira Yokomizo |
title |
Patient‐reported outcomes following neoadjuvant endocrine therapy, external beam radiation, and adjuvant continuous/intermittent endocrine therapy for locally advanced prostate cancer: A randomized phase III trial |
title_short |
Patient‐reported outcomes following neoadjuvant endocrine therapy, external beam radiation, and adjuvant continuous/intermittent endocrine therapy for locally advanced prostate cancer: A randomized phase III trial |
title_full |
Patient‐reported outcomes following neoadjuvant endocrine therapy, external beam radiation, and adjuvant continuous/intermittent endocrine therapy for locally advanced prostate cancer: A randomized phase III trial |
title_fullStr |
Patient‐reported outcomes following neoadjuvant endocrine therapy, external beam radiation, and adjuvant continuous/intermittent endocrine therapy for locally advanced prostate cancer: A randomized phase III trial |
title_full_unstemmed |
Patient‐reported outcomes following neoadjuvant endocrine therapy, external beam radiation, and adjuvant continuous/intermittent endocrine therapy for locally advanced prostate cancer: A randomized phase III trial |
title_sort |
patient‐reported outcomes following neoadjuvant endocrine therapy, external beam radiation, and adjuvant continuous/intermittent endocrine therapy for locally advanced prostate cancer: a randomized phase iii trial |
publisher |
Wiley |
series |
Cancer Medicine |
issn |
2045-7634 |
publishDate |
2021-05-01 |
description |
Abstract Background We evaluated patient‐reported outcomes (PRO) during neoadjuvant androgen deprivation therapy (ADT) plus external beam radiation therapy (EBRT) followed by either adjuvant continuous ADT (CADT) or intermittent ADT (IADT) for patients with locally advanced prostate cancer (Pca). Methods A multicenter, randomized phase III trial enrolled 303 patients with locally advanced Pca. The patients were treated with 6 months (M) of ADT followed by 72 Gy of EBRT, and were randomly assigned to CADT or IADT after 14 M. The PROs were evaluated at sic points: baseline, 6 M, 8 M, 14 M, 20 M, and 38 M using FACT‐P questionnaires and EPIC urinary, bowel, and sexual bother subscales. Results The FACT‐P total scores were significantly better (p < 0.05) in IADT versus CADT at 20 M (121.6 vs.115.4) and at 38 M (119.9 vs. 115.2). The physical well‐being scores (PWB) were significantly better (p < 0.05) in IADT versus CADT at 38 M (25.4 vs. 24.0). The functional scores were significantly better in IADT than those in CADT at 14 M (20.2 vs18.7, p < 0.05) and at 20 M (21.0 vs.18.9, p < 0.05). Conclusion The PRO was significantly favorable in IADT on FACT‐P total score at 20 M and 38 M, PWB and functional scores at 38 M. |
topic |
external beam radiation therapy intermittent androgen deprivation therapy prostate cancer QOL neoadjuvant |
url |
https://doi.org/10.1002/cam4.3895 |
work_keys_str_mv |
AT akirayokomizo patientreportedoutcomesfollowingneoadjuvantendocrinetherapyexternalbeamradiationandadjuvantcontinuousintermittentendocrinetherapyforlocallyadvancedprostatecancerarandomizedphaseiiitrial AT hirofumikoga patientreportedoutcomesfollowingneoadjuvantendocrinetherapyexternalbeamradiationandadjuvantcontinuousintermittentendocrinetherapyforlocallyadvancedprostatecancerarandomizedphaseiiitrial AT kazutoito patientreportedoutcomesfollowingneoadjuvantendocrinetherapyexternalbeamradiationandadjuvantcontinuousintermittentendocrinetherapyforlocallyadvancedprostatecancerarandomizedphaseiiitrial AT yutakatakezawa patientreportedoutcomesfollowingneoadjuvantendocrinetherapyexternalbeamradiationandadjuvantcontinuousintermittentendocrinetherapyforlocallyadvancedprostatecancerarandomizedphaseiiitrial AT motokiyokomiyama patientreportedoutcomesfollowingneoadjuvantendocrinetherapyexternalbeamradiationandadjuvantcontinuousintermittentendocrinetherapyforlocallyadvancedprostatecancerarandomizedphaseiiitrial AT kazuonishimura patientreportedoutcomesfollowingneoadjuvantendocrinetherapyexternalbeamradiationandadjuvantcontinuousintermittentendocrinetherapyforlocallyadvancedprostatecancerarandomizedphaseiiitrial AT junjiyonese patientreportedoutcomesfollowingneoadjuvantendocrinetherapyexternalbeamradiationandadjuvantcontinuousintermittentendocrinetherapyforlocallyadvancedprostatecancerarandomizedphaseiiitrial AT katsuyoshihashine patientreportedoutcomesfollowingneoadjuvantendocrinetherapyexternalbeamradiationandadjuvantcontinuousintermittentendocrinetherapyforlocallyadvancedprostatecancerarandomizedphaseiiitrial AT naoyamasumori patientreportedoutcomesfollowingneoadjuvantendocrinetherapyexternalbeamradiationandadjuvantcontinuousintermittentendocrinetherapyforlocallyadvancedprostatecancerarandomizedphaseiiitrial AT gakuarai patientreportedoutcomesfollowingneoadjuvantendocrinetherapyexternalbeamradiationandadjuvantcontinuousintermittentendocrinetherapyforlocallyadvancedprostatecancerarandomizedphaseiiitrial AT shirosaito patientreportedoutcomesfollowingneoadjuvantendocrinetherapyexternalbeamradiationandadjuvantcontinuousintermittentendocrinetherapyforlocallyadvancedprostatecancerarandomizedphaseiiitrial AT mitsurushinohara patientreportedoutcomesfollowingneoadjuvantendocrinetherapyexternalbeamradiationandadjuvantcontinuousintermittentendocrinetherapyforlocallyadvancedprostatecancerarandomizedphaseiiitrial AT nobuakishimizu patientreportedoutcomesfollowingneoadjuvantendocrinetherapyexternalbeamradiationandadjuvantcontinuousintermittentendocrinetherapyforlocallyadvancedprostatecancerarandomizedphaseiiitrial AT atsushiyamauchi patientreportedoutcomesfollowingneoadjuvantendocrinetherapyexternalbeamradiationandadjuvantcontinuousintermittentendocrinetherapyforlocallyadvancedprostatecancerarandomizedphaseiiitrial AT takefumisatoh patientreportedoutcomesfollowingneoadjuvantendocrinetherapyexternalbeamradiationandadjuvantcontinuousintermittentendocrinetherapyforlocallyadvancedprostatecancerarandomizedphaseiiitrial AT tatsuotochigi patientreportedoutcomesfollowingneoadjuvantendocrinetherapyexternalbeamradiationandadjuvantcontinuousintermittentendocrinetherapyforlocallyadvancedprostatecancerarandomizedphaseiiitrial AT mikiokobayashi patientreportedoutcomesfollowingneoadjuvantendocrinetherapyexternalbeamradiationandadjuvantcontinuousintermittentendocrinetherapyforlocallyadvancedprostatecancerarandomizedphaseiiitrial AT hiroyukifujimoto patientreportedoutcomesfollowingneoadjuvantendocrinetherapyexternalbeamradiationandadjuvantcontinuousintermittentendocrinetherapyforlocallyadvancedprostatecancerarandomizedphaseiiitrial AT kenichikakimoto patientreportedoutcomesfollowingneoadjuvantendocrinetherapyexternalbeamradiationandadjuvantcontinuousintermittentendocrinetherapyforlocallyadvancedprostatecancerarandomizedphaseiiitrial AT iwaofukui patientreportedoutcomesfollowingneoadjuvantendocrinetherapyexternalbeamradiationandadjuvantcontinuousintermittentendocrinetherapyforlocallyadvancedprostatecancerarandomizedphaseiiitrial AT taijitsukamoto patientreportedoutcomesfollowingneoadjuvantendocrinetherapyexternalbeamradiationandadjuvantcontinuousintermittentendocrinetherapyforlocallyadvancedprostatecancerarandomizedphaseiiitrial AT miwakonozaki patientreportedoutcomesfollowingneoadjuvantendocrinetherapyexternalbeamradiationandadjuvantcontinuousintermittentendocrinetherapyforlocallyadvancedprostatecancerarandomizedphaseiiitrial AT katsuyukikarasawa patientreportedoutcomesfollowingneoadjuvantendocrinetherapyexternalbeamradiationandadjuvantcontinuousintermittentendocrinetherapyforlocallyadvancedprostatecancerarandomizedphaseiiitrial AT masaruhasumi patientreportedoutcomesfollowingneoadjuvantendocrinetherapyexternalbeamradiationandadjuvantcontinuousintermittentendocrinetherapyforlocallyadvancedprostatecancerarandomizedphaseiiitrial AT mikinobuohtani patientreportedoutcomesfollowingneoadjuvantendocrinetherapyexternalbeamradiationandadjuvantcontinuousintermittentendocrinetherapyforlocallyadvancedprostatecancerarandomizedphaseiiitrial AT hiromichiishiyama patientreportedoutcomesfollowingneoadjuvantendocrinetherapyexternalbeamradiationandadjuvantcontinuousintermittentendocrinetherapyforlocallyadvancedprostatecancerarandomizedphaseiiitrial AT masaakikuwahara patientreportedoutcomesfollowingneoadjuvantendocrinetherapyexternalbeamradiationandadjuvantcontinuousintermittentendocrinetherapyforlocallyadvancedprostatecancerarandomizedphaseiiitrial AT masaokiharada patientreportedoutcomesfollowingneoadjuvantendocrinetherapyexternalbeamradiationandadjuvantcontinuousintermittentendocrinetherapyforlocallyadvancedprostatecancerarandomizedphaseiiitrial AT yasuoohashi patientreportedoutcomesfollowingneoadjuvantendocrinetherapyexternalbeamradiationandadjuvantcontinuousintermittentendocrinetherapyforlocallyadvancedprostatecancerarandomizedphaseiiitrial AT toshihikokotake patientreportedoutcomesfollowingneoadjuvantendocrinetherapyexternalbeamradiationandadjuvantcontinuousintermittentendocrinetherapyforlocallyadvancedprostatecancerarandomizedphaseiiitrial AT tadaokakizoe patientreportedoutcomesfollowingneoadjuvantendocrinetherapyexternalbeamradiationandadjuvantcontinuousintermittentendocrinetherapyforlocallyadvancedprostatecancerarandomizedphaseiiitrial AT kazuhirosuzuki patientreportedoutcomesfollowingneoadjuvantendocrinetherapyexternalbeamradiationandadjuvantcontinuousintermittentendocrinetherapyforlocallyadvancedprostatecancerarandomizedphaseiiitrial AT seijinaito patientreportedoutcomesfollowingneoadjuvantendocrinetherapyexternalbeamradiationandadjuvantcontinuousintermittentendocrinetherapyforlocallyadvancedprostatecancerarandomizedphaseiiitrial AT hidetoshiyamanaka patientreportedoutcomesfollowingneoadjuvantendocrinetherapyexternalbeamradiationandadjuvantcontinuousintermittentendocrinetherapyforlocallyadvancedprostatecancerarandomizedphaseiiitrial AT nationalresearchprojectonendocrineradiationcombinationtherapyforlocallyadvancedprostatecancerinvestigators patientreportedoutcomesfollowingneoadjuvantendocrinetherapyexternalbeamradiationandadjuvantcontinuousintermittentendocrinetherapyforlocallyadvancedprostatecancerarandomizedphaseiiitrial |
_version_ |
1721439910169149440 |
spelling |
doaj-4fc6d5a819fc4ff3b13b667c17fde3092021-05-16T07:45:27ZengWileyCancer Medicine2045-76342021-05-0110103240324810.1002/cam4.3895Patient‐reported outcomes following neoadjuvant endocrine therapy, external beam radiation, and adjuvant continuous/intermittent endocrine therapy for locally advanced prostate cancer: A randomized phase III trialAkira Yokomizo0Hirofumi Koga1Kazuto Ito2Yutaka Takezawa3Motokiyo Komiyama4Kazuo Nishimura5Junji Yonese6Katsuyoshi Hashine7Naoya Masumori8Gaku Arai9Shiro Saito10Mitsuru Shinohara11Nobuaki Shimizu12Atsushi Yamauchi13Takefumi Satoh14Tatsuo Tochigi15Mikio Kobayashi16Hiroyuki Fujimoto17Ken‐ichi Kakimoto18Iwao Fukui19Taiji Tsukamoto20Miwako Nozaki21Katsuyuki Karasawa22Masaru Hasumi23Mikinobu Ohtani24Hiromichi Ishiyama25Masaaki Kuwahara26Masaoki Harada27Yasuo Ohashi28Toshihiko Kotake29Tadao Kakizoe30Kazuhiro Suzuki31Seiji Naito32Hidetoshi Yamanaka33National Research Project on Endocrine‐Radiation Combination Therapy for Locally Advanced Prostate Cancer investigatorsDepartment of Urology Graduate School of Medicine Kyusyu University Fukuoka JapanDepartment of Urology Graduate School of Medicine Kyusyu University Fukuoka JapanDepartment of Urology Gunma University Graduate School of Medicine Maebashi JapanDepartment of Urology Isesaki Municipal Hospital Isesaki JapanDepartment of Urology National Cancer Center Hospital Tokyo JapanDepartment of Urology Osaka International Cancer Institute Osaka JapanDepartment of Urology Cancer Institute Hospital Tokyo JapanDepartment of Urology Shikoku Cancer Center Matsuyama JapanDepartment of Urology Sapporo Medical University School of Medicine Sapporo JapanDepartment of Urology Dokkyo University Koshigaya Hospital Koshigaya JapanDepartment of Urology Tokyo Medical Center Tokyo JapanDepartment of Urology Tokyo Metropolitan Komagome Hospital Tokyo JapanDepartment of Urology Gunma Cancer Center Hospital Ohta JapanDepartment of Urology Ibaraki Prefectural Central Hospital Kasama JapanDepartment of Urology Kitasato University School of Medicine Sagamihara JapanDepartment of Urology Miyagi Cancer Center Natori JapanDepartment of Urology Isesaki Municipal Hospital Isesaki JapanDepartment of Urology National Cancer Center Hospital Tokyo JapanDepartment of Urology Osaka International Cancer Institute Osaka JapanDepartment of Urology Cancer Institute Hospital Tokyo JapanSapporo Medical University School of Medicine Sapporo JapanDepartment of Radiation Oncology Dokkyo University Koshigaya Hospital Koshigaya JapanDepartment of Radiation Oncology Tokyo Metropolitan Komagome Hospital Tokyo JapanDepartment of Urology Gunma Cancer Center Hospital Ohta JapanDepartment of Urology Ibaraki Prefectural Central Hospital Kasama JapanDepartment of Radiation and Radiation Oncology Kitasato University Sagamihara JapanSendai Jin‐hinyokika Sendai JapanKanagawa Cancer Center Yokohama JapanUniversity of Tokyo Tokyo JapanKotake Clinic Osaka JapanPresident, Japan Cancer Society Tokyo JapanDepartment of Urology Gunma University Graduate School of Medicine Maebashi JapanDepartment of Urology Graduate School of Medicine Kyusyu University Fukuoka JapanInstitute for Preventive Medicine Kurosawa Hospital Takasaki JapanAbstract Background We evaluated patient‐reported outcomes (PRO) during neoadjuvant androgen deprivation therapy (ADT) plus external beam radiation therapy (EBRT) followed by either adjuvant continuous ADT (CADT) or intermittent ADT (IADT) for patients with locally advanced prostate cancer (Pca). Methods A multicenter, randomized phase III trial enrolled 303 patients with locally advanced Pca. The patients were treated with 6 months (M) of ADT followed by 72 Gy of EBRT, and were randomly assigned to CADT or IADT after 14 M. The PROs were evaluated at sic points: baseline, 6 M, 8 M, 14 M, 20 M, and 38 M using FACT‐P questionnaires and EPIC urinary, bowel, and sexual bother subscales. Results The FACT‐P total scores were significantly better (p < 0.05) in IADT versus CADT at 20 M (121.6 vs.115.4) and at 38 M (119.9 vs. 115.2). The physical well‐being scores (PWB) were significantly better (p < 0.05) in IADT versus CADT at 38 M (25.4 vs. 24.0). The functional scores were significantly better in IADT than those in CADT at 14 M (20.2 vs18.7, p < 0.05) and at 20 M (21.0 vs.18.9, p < 0.05). Conclusion The PRO was significantly favorable in IADT on FACT‐P total score at 20 M and 38 M, PWB and functional scores at 38 M.https://doi.org/10.1002/cam4.3895external beam radiation therapyintermittent androgen deprivation therapyprostate cancerQOLneoadjuvant |